Skip to content
Home
News
Corporate
Company Overview & History
Philosophy
CEO’s Message
KIYAN PHARMA Fukuroi Plant
About KIYAN Group
Electronic Public Notices
Business
5-ALA
What is 5-ALA?
5-ALA Manufacturing Business
Pharmaceutical APIs and Intermediates
Health Food & Cosmetics Business
Fertilizer, Feed & Animal Health Business
Drug Development & Licensing Business
Contact Us
Contact Form
Privacy Policy
FAQs (Frequently Asked Questions)
Careers
Japanese
Home
News
Corporate
Company Overview & History
Philosophy
CEO’s Message
KIYAN PHARMA Fukuroi Plant
About KIYAN Group
Electronic Public Notices
Business
5-ALA
What is 5-ALA?
5-ALA Manufacturing Business
Pharmaceutical APIs and Intermediates
Health Food & Cosmetics Business
Fertilizer, Feed & Animal Health Business
Drug Development & Licensing Business
Contact Us
Contact Form
Privacy Policy
FAQs (Frequently Asked Questions)
Careers
Japanese
2021
2021
Home
»
2021
News
Kiku-Masamune Sake Brewing Co., Ltd. Launches “Kiku-Masamune Daiginjo de Ama Sake 5-ALA”
August 31, 2021
News
Launch of the “5-ALA 50mg” Supplement
April 1, 2021
News
Publication of a Paper on the Inhibitory Effect of 5-Aminolevulinic Acid (5-ALA) on the Proliferation of Feline Coronavirus
February 24, 2021
News
Publication of a Paper on the Infection Inhibition of the COVID-19 Virus by 5-Aminolevulinic Acid (5-ALA)
February 9, 2021
Categories
Information
News
Recent Posts
“alapet® Ezo Deer,” a new 5-ALA supplement from KIYAN PHARMA, is now available.– A Veterinarian-Developed Supplement for Dogs and Cats –
November 5, 2025
【Media information】An interview with our Chairman, Hiroyoshi Hata, was featured in the August 2025 issue of Nippon Life’s “Business Management Information” magazine.
September 1, 2025
We have renewed the KIYAN PHARMA website!
May 1, 2024
Intellectual Property High Court Decision on the Patent Infringement Lawsuit against Toa Industry Co., Ltd.
March 28, 2024
Decision on Non-Acceptance of Appeal Concerning the Patent for 5-Aminolevulinic Acid Phosphate
October 10, 2023
Page load link
Go to Top
